Compare XERS & WLTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XERS | WLTH |
|---|---|---|
| Founded | 2005 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2021 | N/A |
| Metric | XERS | WLTH |
|---|---|---|
| Price | $6.67 | $8.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $10.43 | ★ $17.13 |
| AVG Volume (30 Days) | ★ 1.4M | 1.2M |
| Earning Date | 03-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $49,590,000.00 | N/A |
| Revenue This Year | $44.77 | $19.25 |
| Revenue Next Year | $27.72 | $14.99 |
| P/E Ratio | ★ N/A | $10.57 |
| Revenue Growth | ★ 142.67 | N/A |
| 52 Week Low | $3.58 | $7.20 |
| 52 Week High | $10.08 | $14.12 |
| Indicator | XERS | WLTH |
|---|---|---|
| Relative Strength Index (RSI) | 36.92 | 44.20 |
| Support Level | $6.26 | $7.20 |
| Resistance Level | $7.07 | $9.48 |
| Average True Range (ATR) | 0.32 | 0.66 |
| MACD | -0.04 | 0.19 |
| Stochastic Oscillator | 25.94 | 60.53 |
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
Wealthfront Corp is a technology company that built a financial solutions platform for digital natives. Its platform is designed to address the needs of the wealth builders within these generations.